eResearchTechnology, Inc.

Studies awarded for cardiac safety monitoring, information distribution services

Published in Telemedicine Business Week, April 28th, 2004

eResearchTechnology, Inc., (eRT, ERES), a provider of centralized electrocardiographic (ECG) collection and interpretation services, announced that it has been awarded studies totaling more than $1.3 million in cardiac safety monitoring and services from an emerging European biotechnology organization for two of its key drug candidates in later phase clinical trials.

The awards cover a series of phase III studies that target the two compounds and will be conducted at 163 research sites distributed across five continents. eRT will provide comprehensive support and 163 units of digital 12-lead ECG equipment designed to facilitate collection of cardiac safety data that is...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Telemedicine Business Week

Source: Telemedicine Business Week (2004-04-28)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry